Yamazaki M - Search Results

1

Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.

Uemura M, Matsuyama T, Ishikawa M, Fujimoto M, Kojima H, Sakurai S, Ishii S, Toyohara M, Yamazaki M, Yoshiji H, Yamao J, Matsumoto M, Ishizashi H, Fujimura Y, Fukui H. Uemura M, et al. Among authors: yamazaki m. Alcohol Clin Exp Res. 2005 Dec;29(12 Suppl):264S-71S. doi: 10.1097/01.alc.0000192326.08931.cb. Alcohol Clin Exp Res. 2005. PMID: 16385234

2

Extracellular matrix remodeling may predominate over hepatocyte injury in hepatocellular carcinoma development.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu H, Fukui H. Yoshiji H, et al. Among authors: yamazaki m. Oncol Rep. 2003 Jul-Aug;10(4):957-62. Oncol Rep. 2003. PMID: 12792752

3

The copper-chelating agent, trientine, attenuates liver enzyme-altered preneoplastic lesions in rats by angiogenesis suppression.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu H, Fukui H. Yoshiji H, et al. Among authors: yamazaki m. Oncol Rep. 2003 Sep-Oct;10(5):1369-73. Oncol Rep. 2003. PMID: 12883709

4

Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu H, Fukui H. Yoshiji H, et al. Among authors: yamazaki m. Hepatol Res. 2003 Sep;27(1):51-56. doi: 10.1016/s1386-6346(03)00160-8. Hepatol Res. 2003. PMID: 12957207

5

Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.

Noguchi R, Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Mitoro A, Tsujinoue H, Imazu H, Masaki T, Fukui H. Noguchi R, et al. Among authors: yamazaki m. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6038-45. Clin Cancer Res. 2003. PMID: 14676130

6

Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Wu Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Tsujinoue H, Masaki T, Fukui H. Yoshiji H, et al. Among authors: yamazaki m. Hepatology. 2004 Jun;39(6):1517-24. doi: 10.1002/hep.20218. Hepatology. 2004. PMID: 15185292

7

Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Namisaki T, Kitade M, Yamazaki M, Tsujinoue H, Masaki T, Fukui H. Yoshiji H, et al. Among authors: yamazaki m. J Hepatol. 2004 Jul;41(1):97-103. doi: 10.1016/j.jhep.2004.03.001. J Hepatol. 2004. PMID: 15246214

8

Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.

Yoshiji H, Kuriyama S, Noguchi R, Yoshii J, Ikenaka Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Tsujinoue H, Fukui H. Yoshiji H, et al. Among authors: yamazaki m. Liver Int. 2005 Feb;25(1):153-61. doi: 10.1111/j.1478-3231.2005.01038.x. Liver Int. 2005. PMID: 15698413

9

Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.

Yoshiji H, Noguchi R, Kuriyama S, Yoshii J, Ikenaka Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Uemura M, Fukui H. Yoshiji H, et al. Among authors: yamazaki m. Oncol Rep. 2005 May;13(5):853-7. Oncol Rep. 2005. PMID: 15809749

10

Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression.

Yoshiji H, Kuriyama S, Noguchi R, Yoshii J, Ikenaka Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Masaki T, Fukui H. Yoshiji H, et al. Among authors: yamazaki m. J Hepatol. 2005 May;42(5):687-93. doi: 10.1016/j.jhep.2004.12.025. J Hepatol. 2005. PMID: 15826718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,829 results

Search Page

Filters